動物用分子診断市場：製品タイプ、技術、動物タイプ、適応疾患、エンドユーザー別-2025-2030年世界予測

動物用分子診断市場は、2023年に5億7,974万米ドルと評価され、2024年には6億3,240万米ドルに達すると予測され、CAGR 9.17%で成長し、2030年には10億7,185万米ドルに達すると予測されています。

動物用分子診断市場は、PCR、マイクロアレイ、次世代シーケンシング（NGS）のような高度な診断技術に焦点を当て、病原体、遺伝的疾患、その他の分子レベルの健康問題を高い精度で動物に同定します。このような診断の必要性は、人獣共通感染症の流行の増加、動物の健康に対する意識の高まり、食品の安全性強化の必要性から生じています。アプリケーションはコンパニオンアニマル、家畜、研究用家畜の管理にまたがり、獣医師、診断ラボ、研究機関にサービスを提供しています。成長を促進する主な要因は、技術の進歩、ペット飼育の増加、獣医ヘルスケアへの投資、動物疾病の発生率の上昇などです。特筆すべきは、診断におけるAIと機械学習の統合が進んでいることと、低侵襲処置の需要が相まって、大きなビジネスチャンスが生まれていることです。企業は、自動化への投資、検査感度の向上、新規・新興病原体を含む検査提供の拡大により、こうした機会を活用することができます。しかし、市場は分子診断薬のコスト高、新興国地域の限られた獣医学的インフラ、規制上のハードルといった課題に直面しており、これが成長の妨げとなる可能性があります。この分野は、費用対効果の高い技術、携帯型診断装置、包括的ゲノム検査に焦点を当てた技術革新から恩恵を受けることができます。複数の病原体の同時検査が可能なマルチプレックス・アッセイの調査も行われるかもしれないです。市場競争は激しく、既存企業と新興企業が混在して断片化しているため、地理的プレゼンスと製品提供を拡大するための戦略的パートナーシップや提携に注力する必要があります。クラウドベースの動物診断用データ分析における革新は、個別化された動物ケアサービスを強化します。分子診断学に関する獣医師の教育とトレーニングに戦略的に重点を置くことは、採用のために極めて重要です。成長を達成するためには、価格設定の問題に対処し、インフラを拡大し、未開拓の市場における診断サービスへのアクセシビリティを向上させ、これらの革新的な診断ソリューションの普及と影響力を確保する必要があります。

市場力学：急速に進化する動物用分子診断市場の主要市場インサイトを公開

動物用分子診断市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的決定の精緻化、そして新たなビジネスチャンスの獲得に備えることができます。こうした動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができるとともに、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • コンパニオンアニマルおよび家畜の飼育数の増加
  • 経済諸国における獣医療施設の改善
  • 動物の慢性疾患の増加
• 市場抑制要因
  • 高度な分子診断機器とアッセイに伴う高コスト
• 市場機会
  • 動物用分子診断技術の進歩
  • ペット保険の普及
• 市場の課題
  • 熟練した専門家の不足

ポーターの5つの力：動物用分子診断市場をナビゲートする戦略ツール

ポーターの5つの力フレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：動物用分子診断市場における外部からの影響の把握

外部マクロ環境要因は、動物用分子診断市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析動物用分子診断市場における競合情勢の把握

動物用分子診断市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックス動物用分子診断市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、動物用分子診断市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によってベンダーを明確かつ正確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨動物用分子診断市場における成功への道筋を描く

動物用分子診断市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • ペットや家畜の飼育数の増加
    • 経済における獣医ケア施設の改善
    • 動物の慢性疾患の発生率上昇
  • 抑制要因
    • 高度な分子診断機器や検査に伴う高コスト
  • 機会
    • 動物用分子診断テクノロジーの進歩
    • ペット保険の利用可能性が拡大
  • 課題
    • 熟練した専門家の不足
• 市場セグメンテーション分析
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 動物用分子診断市場：製品別

• 機器とソフトウェア
• キットと試薬
• サービス

第7章 動物用分子診断市場：技術別

• DNA配列解析
• マイクロアレイ
• ポリメラーゼ連鎖反応

第8章 動物用分子診断市場動物の種類別

• ペット
  • 犬
  • 馬
  • ネコ科
• 家畜
  • 牛
  • 羊または山羊
  • 豚肉
  • 家禽

第9章 動物用分子診断市場：疾患適応症別

• 下痢病原体の検出
• 呼吸器病原体の検出
• 媒介性感染症

第10章 動物用分子診断市場：エンドユーザー別

• 病院
• リファレンスラボ
• 獣医クリニック

第11章 南北アメリカの動物用分子診断市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第12章 アジア太平洋地域の動物用分子診断市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第13章 欧州・中東・アフリカの動物用分子診断市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第14章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• Biochek BV
• Biomedica Medizinprodukte GmbH
• BioMerieux SA
• Bioneer Corp
• HealthGene Corporation
• Heska Corporation
• IDEXX Laboratories, Inc.
• Novacyt Group
• Quality Vet Lab
• Randox Laboratories, Ltd.
• Thermo Fisher Scientific, Inc.
• VCA, Inc.
• Veterinary Molecular Diagnostics Inc.
• Virbac S.A.
• Zoetis Inc.

LIST OF FIGURES

• FIGURE 1. VETERINARY MOLECULAR DIAGNOSTIC MARKET RESEARCH PROCESS
• FIGURE 2. VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY ANIMAL TYPE, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY ANIMAL TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. GLOBAL VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY DISEASE INDICATION, 2023 VS 2030 (%)
• FIGURE 13. GLOBAL VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY DISEASE INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. GLOBAL VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY END USER, 2023 VS 2030 (%)
• FIGURE 15. GLOBAL VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. AMERICAS VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. AMERICAS VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. UNITED STATES VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 19. UNITED STATES VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. ASIA-PACIFIC VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 21. ASIA-PACIFIC VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 22. EUROPE, MIDDLE EAST & AFRICA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 23. EUROPE, MIDDLE EAST & AFRICA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 24. VETERINARY MOLECULAR DIAGNOSTIC MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 25. VETERINARY MOLECULAR DIAGNOSTIC MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. VETERINARY MOLECULAR DIAGNOSTIC MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. VETERINARY MOLECULAR DIAGNOSTIC MARKET DYNAMICS
• TABLE 7. GLOBAL VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY INSTRUMENTS & SOFTWARE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY KITS & REAGENT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY SERVICES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY DNA SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY MICROARRAYS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY POLYMERASE CHAIN REACTION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY COMPANION ANIMAL, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY CANINE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY EQUINE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY FELINE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY LIVESTOCK ANIMAL, BY REGION, 2018-2030 (USD MILLION)
• TABLE 22. GLOBAL VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY BOVINE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 23. GLOBAL VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY OVINE OR CAPRINE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 24. GLOBAL VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY PORCINE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 25. GLOBAL VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY POULTRY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 26. GLOBAL VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY LIVESTOCK ANIMAL, 2018-2030 (USD MILLION)
• TABLE 27. GLOBAL VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
• TABLE 28. GLOBAL VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY DIARRHEA PATHOGENS DETECTION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 29. GLOBAL VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY RESPIRATORY PATHOGENS DETECTION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 30. GLOBAL VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY VECTOR BORNE DISEASES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 31. GLOBAL VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 32. GLOBAL VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 33. GLOBAL VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY REFERENCE LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 34. GLOBAL VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY VETERNARY CLINICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 35. AMERICAS VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 36. AMERICAS VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 37. AMERICAS VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 38. AMERICAS VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
• TABLE 39. AMERICAS VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY LIVESTOCK ANIMAL, 2018-2030 (USD MILLION)
• TABLE 40. AMERICAS VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
• TABLE 41. AMERICAS VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 42. AMERICAS VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 43. ARGENTINA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 44. ARGENTINA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 45. ARGENTINA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 46. ARGENTINA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
• TABLE 47. ARGENTINA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY LIVESTOCK ANIMAL, 2018-2030 (USD MILLION)
• TABLE 48. ARGENTINA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
• TABLE 49. ARGENTINA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 50. BRAZIL VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 51. BRAZIL VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 52. BRAZIL VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 53. BRAZIL VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
• TABLE 54. BRAZIL VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY LIVESTOCK ANIMAL, 2018-2030 (USD MILLION)
• TABLE 55. BRAZIL VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
• TABLE 56. BRAZIL VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 57. CANADA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 58. CANADA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 59. CANADA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 60. CANADA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
• TABLE 61. CANADA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY LIVESTOCK ANIMAL, 2018-2030 (USD MILLION)
• TABLE 62. CANADA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
• TABLE 63. CANADA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 64. MEXICO VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 65. MEXICO VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 66. MEXICO VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 67. MEXICO VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
• TABLE 68. MEXICO VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY LIVESTOCK ANIMAL, 2018-2030 (USD MILLION)
• TABLE 69. MEXICO VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
• TABLE 70. MEXICO VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 71. UNITED STATES VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 72. UNITED STATES VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 73. UNITED STATES VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 74. UNITED STATES VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
• TABLE 75. UNITED STATES VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY LIVESTOCK ANIMAL, 2018-2030 (USD MILLION)
• TABLE 76. UNITED STATES VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
• TABLE 77. UNITED STATES VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 78. UNITED STATES VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 79. ASIA-PACIFIC VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 80. ASIA-PACIFIC VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 81. ASIA-PACIFIC VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 82. ASIA-PACIFIC VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
• TABLE 83. ASIA-PACIFIC VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY LIVESTOCK ANIMAL, 2018-2030 (USD MILLION)
• TABLE 84. ASIA-PACIFIC VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
• TABLE 85. ASIA-PACIFIC VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 86. ASIA-PACIFIC VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 87. AUSTRALIA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 88. AUSTRALIA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 89. AUSTRALIA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 90. AUSTRALIA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
• TABLE 91. AUSTRALIA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY LIVESTOCK ANIMAL, 2018-2030 (USD MILLION)
• TABLE 92. AUSTRALIA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
• TABLE 93. AUSTRALIA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 94. CHINA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 95. CHINA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 96. CHINA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 97. CHINA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
• TABLE 98. CHINA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY LIVESTOCK ANIMAL, 2018-2030 (USD MILLION)
• TABLE 99. CHINA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
• TABLE 100. CHINA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 101. INDIA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 102. INDIA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 103. INDIA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 104. INDIA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
• TABLE 105. INDIA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY LIVESTOCK ANIMAL, 2018-2030 (USD MILLION)
• TABLE 106. INDIA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
• TABLE 107. INDIA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 108. INDONESIA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 109. INDONESIA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 110. INDONESIA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 111. INDONESIA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
• TABLE 112. INDONESIA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY LIVESTOCK ANIMAL, 2018-2030 (USD MILLION)
• TABLE 113. INDONESIA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
• TABLE 114. INDONESIA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 115. JAPAN VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 116. JAPAN VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 117. JAPAN VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 118. JAPAN VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
• TABLE 119. JAPAN VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY LIVESTOCK ANIMAL, 2018-2030 (USD MILLION)
• TABLE 120. JAPAN VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
• TABLE 121. JAPAN VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 122. MALAYSIA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 123. MALAYSIA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 124. MALAYSIA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 125. MALAYSIA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
• TABLE 126. MALAYSIA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY LIVESTOCK ANIMAL, 2018-2030 (USD MILLION)
• TABLE 127. MALAYSIA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
• TABLE 128. MALAYSIA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 129. PHILIPPINES VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 130. PHILIPPINES VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 131. PHILIPPINES VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 132. PHILIPPINES VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
• TABLE 133. PHILIPPINES VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY LIVESTOCK ANIMAL, 2018-2030 (USD MILLION)
• TABLE 134. PHILIPPINES VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
• TABLE 135. PHILIPPINES VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 136. SINGAPORE VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 137. SINGAPORE VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 138. SINGAPORE VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 139. SINGAPORE VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
• TABLE 140. SINGAPORE VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY LIVESTOCK ANIMAL, 2018-2030 (USD MILLION)
• TABLE 141. SINGAPORE VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
• TABLE 142. SINGAPORE VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 143. SOUTH KOREA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 144. SOUTH KOREA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 145. SOUTH KOREA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 146. SOUTH KOREA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
• TABLE 147. SOUTH KOREA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY LIVESTOCK ANIMAL, 2018-2030 (USD MILLION)
• TABLE 148. SOUTH KOREA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
• TABLE 149. SOUTH KOREA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 150. TAIWAN VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 151. TAIWAN VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 152. TAIWAN VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 153. TAIWAN VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
• TABLE 154. TAIWAN VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY LIVESTOCK ANIMAL, 2018-2030 (USD MILLION)
• TABLE 155. TAIWAN VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
• TABLE 156. TAIWAN VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 157. THAILAND VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 158. THAILAND VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 159. THAILAND VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 160. THAILAND VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
• TABLE 161. THAILAND VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY LIVESTOCK ANIMAL, 2018-2030 (USD MILLION)
• TABLE 162. THAILAND VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
• TABLE 163. THAILAND VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 164. VIETNAM VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 165. VIETNAM VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 166. VIETNAM VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 167. VIETNAM VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
• TABLE 168. VIETNAM VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY LIVESTOCK ANIMAL, 2018-2030 (USD MILLION)
• TABLE 169. VIETNAM VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
• TABLE 170. VIETNAM VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 171. EUROPE, MIDDLE EAST & AFRICA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 172. EUROPE, MIDDLE EAST & AFRICA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 173. EUROPE, MIDDLE EAST & AFRICA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 174. EUROPE, MIDDLE EAST & AFRICA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
• TABLE 175. EUROPE, MIDDLE EAST & AFRICA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY LIVESTOCK ANIMAL, 2018-2030 (USD MILLION)
• TABLE 176. EUROPE, MIDDLE EAST & AFRICA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
• TABLE 177. EUROPE, MIDDLE EAST & AFRICA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 178. EUROPE, MIDDLE EAST & AFRICA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 179. DENMARK VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 180. DENMARK VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 181. DENMARK VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 182. DENMARK VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
• TABLE 183. DENMARK VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY LIVESTOCK ANIMAL, 2018-2030 (USD MILLION)
• TABLE 184. DENMARK VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
• TABLE 185. DENMARK VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 186. EGYPT VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 187. EGYPT VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 188. EGYPT VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 189. EGYPT VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
• TABLE 190. EGYPT VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY LIVESTOCK ANIMAL, 2018-2030 (USD MILLION)
• TABLE 191. EGYPT VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
• TABLE 192. EGYPT VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 193. FINLAND VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 194. FINLAND VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 195. FINLAND VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 196. FINLAND VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
• TABLE 197. FINLAND VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY LIVESTOCK ANIMAL, 2018-2030 (USD MILLION)
• TABLE 198. FINLAND VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
• TABLE 199. FINLAND VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 200. FRANCE VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 201. FRANCE VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 202. FRANCE VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 203. FRANCE VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
• TABLE 204. FRANCE VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY LIVESTOCK ANIMAL, 2018-2030 (USD MILLION)
• TABLE 205. FRANCE VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
• TABLE 206. FRANCE VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 207. GERMANY VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 208. GERMANY VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 209. GERMANY VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 210. GERMANY VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
• TABLE 211. GERMANY VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY LIVESTOCK ANIMAL, 2018-2030 (USD MILLION)
• TABLE 212. GERMANY VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
• TABLE 213. GERMANY VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 214. ISRAEL VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 215. ISRAEL VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 216. ISRAEL VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 217. ISRAEL VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
• TABLE 218. ISRAEL VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY LIVESTOCK ANIMAL, 2018-2030 (USD MILLION)
• TABLE 219. ISRAEL VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
• TABLE 220. ISRAEL VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 221. ITALY VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 222. ITALY VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 223. ITALY VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 224. ITALY VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
• TABLE 225. ITALY VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY LIVESTOCK ANIMAL, 2018-2030 (USD MILLION)
• TABLE 226. ITALY VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
• TABLE 227. ITALY VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 228. NETHERLANDS VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 229. NETHERLANDS VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 230. NETHERLANDS VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 231. NETHERLANDS VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
• TABLE 232. NETHERLANDS VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY LIVESTOCK ANIMAL, 2018-2030 (USD MILLION)
• TABLE 233. NETHERLANDS VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
• TABLE 234. NETHERLANDS VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 235. NIGERIA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 236. NIGERIA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 237. NIGERIA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 238. NIGERIA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
• TABLE 239. NIGERIA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY LIVESTOCK ANIMAL, 2018-2030 (USD MILLION)
• TABLE 240. NIGERIA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
• TABLE 241. NIGERIA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 242. NORWAY VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 243. NORWAY VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 244. NORWAY VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 245. NORWAY VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
• TABLE 246. NORWAY VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY LIVESTOCK ANIMAL, 2018-2030 (USD MILLION)
• TABLE 247. NORWAY VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
• TABLE 248. NORWAY VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 249. POLAND VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 250. POLAND VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 251. POLAND VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 252. POLAND VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
• TABLE 253. POLAND VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY LIVESTOCK ANIMAL, 2018-2030 (USD MILLION)
• TABLE 254. POLAND VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
• TABLE 255. POLAND VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 256. QATAR VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 257. QATAR VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 258. QATAR VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 259. QATAR VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
• TABLE 260. QATAR VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY LIVESTOCK ANIMAL, 2018-2030 (USD MILLION)
• TABLE 261. QATAR VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
• TABLE 262. QATAR VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 263. RUSSIA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 264. RUSSIA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 265. RUSSIA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 266. RUSSIA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
• TABLE 267. RUSSIA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY LIVESTOCK ANIMAL, 2018-2030 (USD MILLION)
• TABLE 268. RUSSIA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
• TABLE 269. RUSSIA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 270. SAUDI ARABIA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 271. SAUDI ARABIA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 272. SAUDI ARABIA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 273. SAUDI ARABIA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
• TABLE 274. SAUDI ARABIA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY LIVESTOCK ANIMAL, 2018-2030 (USD MILLION)
• TABLE 275. SAUDI ARABIA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
• TABLE 276. SAUDI ARABIA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 277. SOUTH AFRICA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 278. SOUTH AFRICA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 279. SOUTH AFRICA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 280. SOUTH AFRICA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
• TABLE 281. SOUTH AFRICA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY LIVESTOCK ANIMAL, 2018-2030 (USD MILLION)
• TABLE 282. SOUTH AFRICA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
• TABLE 283. SOUTH AFRICA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 284. SPAIN VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 285. SPAIN VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 286. SPAIN VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 287. SPAIN VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
• TABLE 288. SPAIN VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY LIVESTOCK ANIMAL, 2018-2030 (USD MILLION)
• TABLE 289. SPAIN VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
• TABLE 290. SPAIN VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 291. SWEDEN VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 292. SWEDEN VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 293. SWEDEN VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 294. SWEDEN VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
• TABLE 295. SWEDEN VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY LIVESTOCK ANIMAL, 2018-2030 (USD MILLION)
• TABLE 296. SWEDEN VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
• TABLE 297. SWEDEN VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 298. SWITZERLAND VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 299. SWITZERLAND VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 300. SWITZERLAND VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 301. SWITZERLAND VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
• TABLE 302. SWITZERLAND VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY LIVESTOCK ANIMAL, 2018-2030 (USD MILLION)
• TABLE 303. SWITZERLAND VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
• TABLE 304. SWITZERLAND VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 305. TURKEY VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 306. TURKEY VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 307. TURKEY VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 308. TURKEY VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
• TABLE 309. TURKEY VETERINARY MOLEC

The Veterinary Molecular Diagnostic Market was valued at USD 579.74 million in 2023, expected to reach USD 632.40 million in 2024, and is projected to grow at a CAGR of 9.17%, to USD 1,071.85 million by 2030.

The veterinary molecular diagnostic market focuses on advanced diagnostic techniques like PCR, microarrays, and next-generation sequencing (NGS) to identify pathogens, genetic disorders, and other molecular-level health issues in animals with high accuracy. The necessity for such diagnostics arises from the increased prevalence of zoonotic diseases, growing awareness toward animal health, and the need for enhanced food safety. Applications span across companion animals, livestock, and research livestock management, serving veterinarians, diagnostic labs, and research institutes. Key factors driving growth include technological advancements, increased pet ownership, investments in veterinary healthcare, and the rising incidence of animal diseases. Notably, the growing integration of AI and machine learning in diagnostics, combined with the demand for minimally invasive procedures, creates significant opportunities. Companies can capitalize on these opportunities by investing in automation, enhancing test sensitivity, and broadening their test offerings to include novel and emerging pathogens. However, the market faces challenges such as high costs of molecular diagnostics, limited veterinary infrastructure in developing regions, and regulatory hurdles, which can impede growth. The field can benefit from innovations focused on cost-effective technologies, portable diagnostic devices, and comprehensive genomic testing. Research might explore multiplex assays capable of simultaneous testing for multiple pathogens. The market is competitive and fragmented with a mix of established firms and startups, necessitating a focus on strategic partnerships and collaborations to expand geographical presence and product offerings. Innovation in cloud-based data analytics for veterinary diagnostics will enhance personalized animal care services. Strategic focus on education and training for veterinarians on molecular diagnostics is crucial for adoption. Achieving growth requires addressing pricing issues, scaling up infrastructure, and increasing accessibility to diagnostic services in untapped markets, ensuring a wider reach and impact of these innovative diagnostic solutions.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Veterinary Molecular Diagnostic Market

The Veterinary Molecular Diagnostic Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Increasing number of companion animal and livestock ownership
  • Improving veterinary care facilities in economies
  • Rising incidence of chronic diseases in animals
• Market Restraints
  • High cost associated with sophisticated molecular diagnostics instruments and assays
• Market Opportunities
  • Advances in veterinary molecular diagnostic technology
  • Growing availability of pet insurance
• Market Challenges
  • Lack of skilled professionals

Porter's Five Forces: A Strategic Tool for Navigating the Veterinary Molecular Diagnostic Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Veterinary Molecular Diagnostic Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Veterinary Molecular Diagnostic Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Veterinary Molecular Diagnostic Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Veterinary Molecular Diagnostic Market

A detailed market share analysis in the Veterinary Molecular Diagnostic Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Veterinary Molecular Diagnostic Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Veterinary Molecular Diagnostic Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Veterinary Molecular Diagnostic Market

A strategic analysis of the Veterinary Molecular Diagnostic Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Veterinary Molecular Diagnostic Market, highlighting leading vendors and their innovative profiles. These include Biochek BV, Biomedica Medizinprodukte GmbH, BioMerieux SA, Bioneer Corp, HealthGene Corporation, Heska Corporation, IDEXX Laboratories, Inc., Novacyt Group, Quality Vet Lab, Randox Laboratories, Ltd., Thermo Fisher Scientific, Inc., VCA, Inc., Veterinary Molecular Diagnostics Inc., Virbac S.A., and Zoetis Inc..

Market Segmentation & Coverage

This research report categorizes the Veterinary Molecular Diagnostic Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Product, market is studied across Instruments & Software, Kits & Reagent, and Services.
• Based on Technology, market is studied across DNA Sequencing, Microarrays, and Polymerase Chain Reaction.
• Based on Animal Type, market is studied across Companion Animal and Livestock Animal. The Companion Animal is further studied across Canine, Equine, and Feline. The Livestock Animal is further studied across Bovine, Ovine or Caprine, Porcine, and Poultry.
• Based on Disease Indication, market is studied across Diarrhea Pathogens Detection, Respiratory Pathogens Detection, and Vector Borne Diseases.
• Based on End User, market is studied across Hospitals, Reference Laboratories, and Veternary Clinics.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increasing number of companion animal and livestock ownership
    • 5.1.1.2. Improving veterinary care facilities in economies
    • 5.1.1.3. Rising incidence of chronic diseases in animals
  • 5.1.2. Restraints
    • 5.1.2.1. High cost associated with sophisticated molecular diagnostics instruments and assays
  • 5.1.3. Opportunities
    • 5.1.3.1. Advances in veterinary molecular diagnostic technology
    • 5.1.3.2. Growing availability of pet insurance
  • 5.1.4. Challenges
    • 5.1.4.1. Lack of skilled professionals
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Veterinary Molecular Diagnostic Market, by Product

• 6.1. Introduction
• 6.2. Instruments & Software
• 6.3. Kits & Reagent
• 6.4. Services

7. Veterinary Molecular Diagnostic Market, by Technology

• 7.1. Introduction
• 7.2. DNA Sequencing
• 7.3. Microarrays
• 7.4. Polymerase Chain Reaction

8. Veterinary Molecular Diagnostic Market, by Animal Type

• 8.1. Introduction
• 8.2. Companion Animal
  • 8.2.1. Canine
  • 8.2.2. Equine
  • 8.2.3. Feline
• 8.3. Livestock Animal
  • 8.3.1. Bovine
  • 8.3.2. Ovine or Caprine
  • 8.3.3. Porcine
  • 8.3.4. Poultry

9. Veterinary Molecular Diagnostic Market, by Disease Indication

• 9.1. Introduction
• 9.2. Diarrhea Pathogens Detection
• 9.3. Respiratory Pathogens Detection
• 9.4. Vector Borne Diseases

10. Veterinary Molecular Diagnostic Market, by End User

• 10.1. Introduction
• 10.2. Hospitals
• 10.3. Reference Laboratories
• 10.4. Veternary Clinics

11. Americas Veterinary Molecular Diagnostic Market

• 11.1. Introduction
• 11.2. Argentina
• 11.3. Brazil
• 11.4. Canada
• 11.5. Mexico
• 11.6. United States

12. Asia-Pacific Veterinary Molecular Diagnostic Market

• 12.1. Introduction
• 12.2. Australia
• 12.3. China
• 12.4. India
• 12.5. Indonesia
• 12.6. Japan
• 12.7. Malaysia
• 12.8. Philippines
• 12.9. Singapore
• 12.10. South Korea
• 12.11. Taiwan
• 12.12. Thailand
• 12.13. Vietnam

13. Europe, Middle East & Africa Veterinary Molecular Diagnostic Market

• 13.1. Introduction
• 13.2. Denmark
• 13.3. Egypt
• 13.4. Finland
• 13.5. France
• 13.6. Germany
• 13.7. Israel
• 13.8. Italy
• 13.9. Netherlands
• 13.10. Nigeria
• 13.11. Norway
• 13.12. Poland
• 13.13. Qatar
• 13.14. Russia
• 13.15. Saudi Arabia
• 13.16. South Africa
• 13.17. Spain
• 13.18. Sweden
• 13.19. Switzerland
• 13.20. Turkey
• 13.21. United Arab Emirates
• 13.22. United Kingdom

14. Competitive Landscape

• 14.1. Market Share Analysis, 2023
• 14.2. FPNV Positioning Matrix, 2023
• 14.3. Competitive Scenario Analysis
• 14.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Biochek BV
• 2. Biomedica Medizinprodukte GmbH
• 3. BioMerieux SA
• 4. Bioneer Corp
• 5. HealthGene Corporation
• 6. Heska Corporation
• 7. IDEXX Laboratories, Inc.
• 8. Novacyt Group
• 9. Quality Vet Lab
• 10. Randox Laboratories, Ltd.
• 11. Thermo Fisher Scientific, Inc.
• 12. VCA, Inc.
• 13. Veterinary Molecular Diagnostics Inc.
• 14. Virbac S.A.
• 15. Zoetis Inc.